908 Devices Inc. (MASS)
USD 3.74
(-4.1%)
USD 3.74
(-4.1%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 68.08 Million USD | 7.11% |
| 2022 | 61.4 Million USD | 35.55% |
| 2021 | 45.3 Million USD | 118.45% |
| 2020 | 20.73 Million USD | 2.22% |
| 2019 | 20.28 Million USD | 7.73% |
| 2018 | 18.83 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 16.58 Million USD | -0.52% |
| 2024 Q2 | 5.31 Million USD | 26.5% |
| 2023 Q4 | 16.66 Million USD | -1.7% |
| 2023 Q1 | 17.4 Million USD | 7.02% |
| 2023 Q2 | 16.73 Million USD | -3.84% |
| 2023 FY | 65.76 Million USD | 7.11% |
| 2023 Q3 | 16.95 Million USD | 1.34% |
| 2022 FY | 61.4 Million USD | 35.55% |
| 2022 Q4 | 16.26 Million USD | -1.41% |
| 2022 Q3 | 16.49 Million USD | 9.92% |
| 2022 Q2 | 15 Million USD | 9.91% |
| 2022 Q1 | 13.65 Million USD | 7.8% |
| 2021 FY | 45.3 Million USD | 118.45% |
| 2021 Q3 | 12.08 Million USD | 2.15% |
| 2021 Q2 | 11.83 Million USD | 35.74% |
| 2021 Q4 | 12.66 Million USD | 4.75% |
| 2021 Q1 | 8.71 Million USD | 34.85% |
| 2020 Q3 | 5.12 Million USD | 19.78% |
| 2020 Q2 | 4.28 Million USD | -11.93% |
| 2020 Q1 | 4.86 Million USD | 4.72% |
| 2020 FY | 20.73 Million USD | 2.22% |
| 2020 Q4 | 6.46 Million USD | 26.05% |
| 2019 Q2 | 5.42 Million USD | 2.55% |
| 2019 Q1 | 5.29 Million USD | 0.0% |
| 2019 FY | 20.28 Million USD | 7.73% |
| 2019 Q4 | 4.64 Million USD | -7.68% |
| 2019 Q3 | 5.02 Million USD | -7.37% |
| 2018 FY | 18.83 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -506.557% |
| Cerus Corporation | 143.15 Million USD | 52.443% |
| OrthoPediatrics Corp. | 137.01 Million USD | 50.313% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -499.25% |
| Talis Biomedical Corporation | 67.18 Million USD | -1.331% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -172.909% |
| Inogen, Inc. | 236.08 Million USD | 71.163% |
| Spectral AI, Inc. | 20.86 Million USD | -226.304% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -21.578% |
| CVRx, Inc. | 76.14 Million USD | 10.588% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1829.707% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -445.12% |
| Orthofix Medical Inc. | 667.42 Million USD | 89.8% |
| Venus Concept Inc. | 80.47 Million USD | 15.403% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -20.329% |
| Bioventus Inc. | 409.91 Million USD | 83.392% |
| BrainsWay Ltd. | 28.01 Million USD | -142.987% |
| Envoy Medical, Inc. | 17.89 Million USD | -280.378% |
| electroCore, Inc. | 32.03 Million USD | -112.544% |
| IceCure Medical Ltd | 16.87 Million USD | -303.413% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -60.445% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -286.094% |
| MaxCyte, Inc. | 84.84 Million USD | 19.76% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -448.512% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1077.578% |
| PAVmed Inc | 64.82 Million USD | -5.018% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -33.286% |
| RxSight, Inc. | 103.85 Million USD | 34.444% |
| Sight Sciences, Inc. | 126.44 Million USD | 46.16% |
| SI-BONE, Inc. | 156.35 Million USD | 56.457% |
| TELA Bio, Inc. | 84.18 Million USD | 19.132% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 2.821% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 66.523% |
| LivaNova PLC | 843.54 Million USD | 91.929% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 85.922% |
| Nemaura Medical Inc. | 7.13 Million USD | -853.661% |
| NeuroPace, Inc. | 75.29 Million USD | 9.584% |
| LENSAR, Inc. | 33.33 Million USD | -104.224% |
| Apyx Medical Corporation | 51.01 Million USD | -33.443% |
| Cutera, Inc. | 197.72 Million USD | 65.568% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -174.727% |
| BioSig Technologies, Inc. | 28.53 Million USD | -138.626% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 64.444% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -88.796% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 91.86% |
| Axonics, Inc. | 270.2 Million USD | 74.804% |
| Outset Medical, Inc. | 198.77 Million USD | 65.749% |
| IRIDEX Corporation | 31.81 Million USD | -113.994% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 62.224% |
| IRadimed Corporation | 30.12 Million USD | -126.008% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -697.937% |
| INVO Bioscience, Inc. | 7.85 Million USD | -766.897% |
| Telesis Bio, Inc. | 63.48 Million USD | -7.231% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 30.85% |
| Varex Imaging Corporation | 224.8 Million USD | 69.715% |
| Quipt Home Medical Corp. | 148.66 Million USD | 54.206% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -480.739% |
| Pulmonx Corporation | 112.68 Million USD | 39.585% |
| Dynatronics Corporation | 9.9 Million USD | -587.12% |
| Modular Medical, Inc. | 17.52 Million USD | -288.385% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -237.247% |
| Semler Scientific, Inc. | 38.94 Million USD | -74.815% |
| InMode Ltd. | 215.68 Million USD | 68.435% |
| Bruker Corporation | 1.07 Billion USD | 93.675% |
| Cytosorbents Corporation | 48.33 Million USD | -40.845% |
| DexCom, Inc. | 1.69 Billion USD | 95.974% |
| Align Technology, Inc. | 2.07 Billion USD | 96.722% |
| Viveve Medical, Inc. | 22.17 Million USD | -207.04% |
| ZimVie Inc. | 275.12 Million USD | 75.255% |
| Movano Inc. | 29.69 Million USD | -129.303% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 50.405% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1077.578% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1829.707% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 88.671% |
| Profound Medical Corp. | 33.6 Million USD | -102.6% |
| Insulet Corporation | 939.9 Million USD | 92.757% |
| enVVeno Medical Corporation | 25.23 Million USD | -169.752% |
| Surmodics, Inc. | 98.69 Million USD | 31.021% |
| iCAD, Inc. | 22.22 Million USD | -206.322% |
| Nuwellis, Inc. | 22.61 Million USD | -201.066% |
| Biotricity, Inc. | 17.18 Million USD | -296.17% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 84.732% |
| Aethlon Medical, Inc. | 12.27 Million USD | -454.51% |
| InspireMD, Inc. | 22.95 Million USD | -196.645% |
| PAVmed Inc. | 64.82 Million USD | -5.018% |
| BIOLASE, Inc. | 34.66 Million USD | -96.417% |
| Beyond Air, Inc. | 61.7 Million USD | -10.34% |
| FONAR Corporation | 28.6 Million USD | -138.003% |
| AxoGen, Inc. | 149.33 Million USD | 54.412% |
| Vivani Medical, Inc. | 26.96 Million USD | -152.475% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 61.557% |
| Inari Medical, Inc. | 448.59 Million USD | 84.824% |
| UFP Technologies, Inc. | 58.08 Million USD | -17.199% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1281.606% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -977.507% |
| Tenon Medical, Inc. | 16.96 Million USD | -301.226% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -820.871% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -54.366% |
| AdaptHealth Corp. | 1.07 Billion USD | 93.684% |
| Sintx Technologies, Inc. | 15.2 Million USD | -347.865% |
| NanoVibronix, Inc. | 4.97 Million USD | -1268.993% |
| Quanterix Corporation | 118.1 Million USD | 42.354% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -480.739% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -371.403% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 82.662% |
| TransMedics Group, Inc. | 182.82 Million USD | 62.761% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -142.58% |
| NeuroMetrix, Inc. | 11.09 Million USD | -513.392% |
| Hyperfine, Inc. | 52.87 Million USD | -28.764% |
| Establishment Labs Holdings Inc. | 172 Million USD | 60.419% |
| Biomerica, Inc. | 6.97 Million USD | -875.638% |
| Bone Biologics Corporation | 9.42 Million USD | -622.081% |
| AVITA Medical, Inc. | 80.77 Million USD | 15.721% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -560.252% |
| Silk Road Medical, Inc | 186.35 Million USD | 63.468% |